Who founded Concarlo?

Concarlo was founded by Stacy Blain.

Who are Concarlo's investors?

Concarlo's investors include BioAdvance, Creative Destruction Lab (CDL), Raptor Group.

How much funding has Concarlo raised?

Concarlo has disclosed $450K raised across 1 round.

Where is Concarlo headquartered?

Concarlo is headquartered in Brooklyn, US.

Concarlo

Brooklyn, US · 3 known investors

Concarlo Therapeutics develops cancer therapeutics that target CDK4/6-driven cell proliferation and CDK2-driven resistance, focusing on improving outcomes for cancer patients through novel approaches in p27 biology.

Biotech

Founders & leadership

Stacy BlainFounder and CEO

LisaMarie CaseyPresident and Manager

Investors · 3

BioAdvanceConshohocken · $500K – $1.5M

Creative Destruction Lab (CDL)Toronto · $50K – $250K

Raptor GroupMiami Beachvia James J. Pallotta · inferred

Reported raises · per SEC filings

Form D private placements

$450K disclosed across 1 round · 2017

▶$450KraisedMar 2017 · 6 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

LisaMarie CaseyExecutive Officer, Director

Offering amount: $1.2M
Amount sold: $450K
Minimum investment: $25K
First sale: Mar 2017
Incorporated: Limited Liability Company, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 4

by search overlap

Applied Therapeutics7 shared keywordsApplied Therapeutics is a biopharmaceutical company developing novel drugs for rare diseases with high unmet medical need. Its Aldose Reductase Inhibitor franchise is in development across disease areas including Galactosemia and SORD Deficiency.

Protara Therapeutics6 shared keywordsProtara develops transformative therapies for patients with cancer and rare diseases, applying modern scientific and manufacturing advancements to accelerate drug development.

Capricor6 shared keywordsCapricor Therapeutics is a biotechnology company developing allogeneic cardiosphere-derived cell (CDC) and exosome-based therapeutics to treat serious diseases including Duchenne muscular dystrophy. The company uses cell and exosome biology platforms to create novel therapeutic medicines for patient treatment.

Certara6 shared keywordsCertara provides biosimulation software, modeling, and regulatory services that support drug discovery and development across discovery, preclinical, clinical, regulatory, and market access phases. It serves pharmaceutical and biotech organizations seeking to make data-driven decisions and streamline regulatory submissions.

Companies competing with Concarlo for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Concarlo do?: Concarlo Therapeutics develops cancer therapeutics that target CDK4/6-driven cell proliferation and CDK2-driven resistance, focusing on improving outcomes for cancer patients through novel approaches in p27 biology.
Who founded Concarlo?: Concarlo was founded by Stacy Blain.
Who are Concarlo's investors?: Concarlo's investors include BioAdvance, Creative Destruction Lab (CDL), Raptor Group.
How much funding has Concarlo raised?: Concarlo has disclosed $450K raised across 1 round.
Where is Concarlo headquartered?: Concarlo is headquartered in Brooklyn, US.